Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.80M | 4.86M | 10.04M | 9.39M | 11.70M |
| Total Receivables | 234.00K | 456.00K | 323.00K | 383.00K | 484.00K |
| Inventory | -- | -- | 53.00K | 66.00K | 437.00K |
| Prepaid Expenses | 400.00K | 822.00K | 747.00K | 1.16M | 1.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 345.00K | 1.12M | 2.10M |
| Total Current Assets | 3.43M | 6.14M | 11.51M | 12.13M | 16.25M |
|
|
|||||
| Total Current Assets | 3.43M | 6.14M | 11.51M | 12.13M | 16.25M |
| Net Property, Plant & Equipment | 817.00K | 827.00K | 2.65M | 2.84M | 2.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.98M | 2.22M | 1.05M | 8.07M | 7.77M |
| Total Assets | 6.23M | 9.18M | 15.21M | 23.04M | 26.81M |
|
|
|||||
| Total Accounts Payable | 510.00K | 1.04M | 655.00K | 897.00K | 1.04M |
| Total Accrued Expenses | 310.00K | 788.00K | 1.15M | 1.33M | 1.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 182.00K | 323.00K | 565.00K | 550.00K | 454.00K |
| Total Finance Division Other Current Liabilities | 199.00K | 326.00K | 1.29M | 3.92M | 4.68M |
| Total Other Current Liabilities | 199.00K | 326.00K | 1.29M | 3.92M | 4.68M |
| Total Current Liabilities | 1.20M | 2.47M | 3.67M | 6.69M | 7.51M |
|
|
|||||
| Total Current Liabilities | 1.20M | 2.47M | 3.67M | 6.69M | 7.51M |
| Long-Term Debt | 57.00K | 57.00K | 57.00K | 57.00K | 57.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 469.00K | 573.00K | 1.57M | 1.72M | 1.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 728.00K | 780.00K |
| Total Liabilities | 1.73M | 3.10M | 5.30M | 9.20M | 10.02M |
|
|
|||||
| Common Stock & APIC | 112.11M | 112.06M | 111.44M | 111.01M | 110.63M |
| Retained Earnings | -107.61M | -105.98M | -101.50M | -97.24M | -93.78M |
| Treasury Stock & Other | -- | -- | -32.00K | 74.00K | -62.00K |
| Total Common Equity | 4.50M | 6.08M | 9.91M | 13.84M | 16.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.50M | 6.08M | 9.91M | 13.84M | 16.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.50M | 6.08M | 9.91M | 13.84M | 16.79M |
|
|
|||||